search
Back to results

Evaluation of the Synergistic Impact of Needle and Forceps Biopsy With Electromagnetic Navigation Bronchoscopy

Primary Purpose

Lung Cancer, Lung Cancer (Diagnosis)

Status
Recruiting
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Device for performing biopsy via electromagnetic navigation bronchoscopy
Sponsored by
Seoul National University Bundang Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Lung Cancer focused on measuring Electromagnetic Navigation Bronchoscopy, Bronchoscopy, Diagnosis

Eligibility Criteria

19 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with lung lesions suspicious for malignancy and needs tissue confirmation, with a positive bronchus sign and feasible for ENB

Exclusion Criteria:

  • Patients who disagree to participate

Sites / Locations

  • Seoul National University Bundang HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Needle-centered

Forceps-centered

Arm Description

Participants affiliated to this arm will undergo ENB-guided biopsy with needle aspiration first, followed by forceps biopsy

Participants affiliated to this arm will undergo ENB-guided biopsy with forceps first, followed by needle aspiration.

Outcomes

Primary Outcome Measures

Diagnostic yield at 12 months
([True positive + True negative]/All biopsied performed) Pathologic results of a malignant or benign specific diagnosis based on the samples collected via index ENB procedure are categorized as true positives or true negatives. For pathologic results of a benign non-specific diagnosis, follow-up data would be used to determine whether the 12-month status corroborates the benign results. Pathologic results that are non-diagnostic at index would be determined as false negatives.

Secondary Outcome Measures

Diagnostic yield at index
The proportion of pathologic results that leads to a specific malignant or benign diagnosis
Sensitivity of needle or forceps biopsy for diagnosis of malignancy
True positive/Confirmed malignancy cases
Duration of procedure
Total duration and time per sampling for needle and forceps biopsy

Full Information

First Posted
October 14, 2021
Last Updated
May 31, 2023
Sponsor
Seoul National University Bundang Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05110131
Brief Title
Evaluation of the Synergistic Impact of Needle and Forceps Biopsy With Electromagnetic Navigation Bronchoscopy
Official Title
Comparison and Synergistic Evaluation of Needle Aspiration and Forceps Biopsy for Diagnosis of Lung Lesions With Electromagnetic Navigation Bronchoscopy
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 4, 2022 (Actual)
Primary Completion Date
December 30, 2023 (Anticipated)
Study Completion Date
December 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Seoul National University Bundang Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This randomized crossover study aimed to compare the diagnostic performance of needle aspiration biopsy and forceps biopsy for diagnosis of pulmonary lesions with electromagnetic navigation bronchoscopy, and whether combination of the two methods (needle and forceps) can provide additive benefit for diagnosis.
Detailed Description
This randomized crossover study aimed to evaluate whether combining electromagnetic navigation bronchoscopy (ENB)-guided needle aspiration and forceps biopsy provides synergistic benefits, and compare the diagnostic performance of needle aspiration biopsy and forceps biopsy for diagnosis of pulmonary lesions. The investigators designed this study to prospectively enroll patients with lung lesions suspicious for lung cancer with positive bronchus sign and feasible for undergoing electromagnetic bronchoscopy under moderate sedation. Participants will be randomized to two groups. One group will receive ENB-guided biopsy with lung lesion with needle aspiration followed by forceps biopsy (needle-centered group), while the other groups will receive the same procedure with forceps biopsy followed by needle aspiration biopsy (forceps-centered group). All participants will undergo ENB under moderate sedation without the concurrent use of other guiding techniques such as fluoroscopy, radial endobronchial sonography. All participants will be followed up for 1 year to confirm the final diagnosis. The primary endpoint is the diagnostic performance of ENB-guided needle biopsy and forceps biopsy and the yield achieved by combining the modalities based on the 12-month clinical follow-up. Secondary endpoints include a comparison of successful approach to the lesion, duration of sampling time, number of attempts, and successful acquisition of core tissue between the needle and forceps biopsy techniques.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lung Cancer, Lung Cancer (Diagnosis)
Keywords
Electromagnetic Navigation Bronchoscopy, Bronchoscopy, Diagnosis

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Randomized crossover design
Masking
ParticipantCare ProviderInvestigator
Masking Description
The attending physician and patient will be blinded to the randomized group and which method of biopsy (needle or forceps) would be performed first. The pulmonologist performing the ENB procedure will be informed just before the start of the procedure which group the patient is affiliated to.
Allocation
Randomized
Enrollment
142 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Needle-centered
Arm Type
Active Comparator
Arm Description
Participants affiliated to this arm will undergo ENB-guided biopsy with needle aspiration first, followed by forceps biopsy
Arm Title
Forceps-centered
Arm Type
Active Comparator
Arm Description
Participants affiliated to this arm will undergo ENB-guided biopsy with forceps first, followed by needle aspiration.
Intervention Type
Device
Intervention Name(s)
Device for performing biopsy via electromagnetic navigation bronchoscopy
Intervention Description
Device for performing biopsy via electromagnetic navigation bronchoscopy (needle and forceps)
Primary Outcome Measure Information:
Title
Diagnostic yield at 12 months
Description
([True positive + True negative]/All biopsied performed) Pathologic results of a malignant or benign specific diagnosis based on the samples collected via index ENB procedure are categorized as true positives or true negatives. For pathologic results of a benign non-specific diagnosis, follow-up data would be used to determine whether the 12-month status corroborates the benign results. Pathologic results that are non-diagnostic at index would be determined as false negatives.
Time Frame
Confirmed by follow-up results at 1 year
Secondary Outcome Measure Information:
Title
Diagnostic yield at index
Description
The proportion of pathologic results that leads to a specific malignant or benign diagnosis
Time Frame
At index procedure
Title
Sensitivity of needle or forceps biopsy for diagnosis of malignancy
Description
True positive/Confirmed malignancy cases
Time Frame
Confirmed by follow-up results at 12 months
Title
Duration of procedure
Description
Total duration and time per sampling for needle and forceps biopsy
Time Frame
At index procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with lung lesions suspicious for malignancy and needs tissue confirmation, with a positive bronchus sign and feasible for ENB Exclusion Criteria: Patients who disagree to participate
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yeon Wook Kim, MD., PhD
Phone
82-31-787-8134
Email
kimyw@snu.ac.kr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yeon Wook Kim, MD., PhD
Organizational Affiliation
Seoul National University Bundang Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Seoul National University Bundang Hospital
City
Seongnam-si
State/Province
Gyeonggi-do
ZIP/Postal Code
13620
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yeon Wook Kim, Professor
Phone
82-10-7497-5586
Email
kimyw@snu.ac.kr

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30476574
Citation
Folch EE, Pritchett MA, Nead MA, Bowling MR, Murgu SD, Krimsky WS, Murillo BA, LeMense GP, Minnich DJ, Bansal S, Ellis BQ, Mahajan AK, Gildea TR, Bechara RI, Sztejman E, Flandes J, Rickman OB, Benzaquen S, Hogarth DK, Linden PA, Wahidi MM, Mattingley JS, Hood KL, Lin H, Wolvers JJ, Khandhar SJ; NAVIGATE Study Investigators. Electromagnetic Navigation Bronchoscopy for Peripheral Pulmonary Lesions: One-Year Results of the Prospective, Multicenter NAVIGATE Study. J Thorac Oncol. 2019 Mar;14(3):445-458. doi: 10.1016/j.jtho.2018.11.013. Epub 2018 Nov 23.
Results Reference
background
PubMed Identifier
34506792
Citation
Vachani A, Maldonado F, Laxmanan B, Kalsekar I, Murgu S. The Impact of Alternative Approaches to Diagnostic Yield Calculation in Studies of Bronchoscopy. Chest. 2022 May;161(5):1426-1428. doi: 10.1016/j.chest.2021.08.074. Epub 2021 Sep 7. No abstract available.
Results Reference
background
PubMed Identifier
26367186
Citation
Ost DE, Ernst A, Lei X, Kovitz KL, Benzaquen S, Diaz-Mendoza J, Greenhill S, Toth J, Feller-Kopman D, Puchalski J, Baram D, Karunakara R, Jimenez CA, Filner JJ, Morice RC, Eapen GA, Michaud GC, Estrada-Y-Martin RM, Rafeq S, Grosu HB, Ray C, Gilbert CR, Yarmus LB, Simoff M; AQuIRE Bronchoscopy Registry. Diagnostic Yield and Complications of Bronchoscopy for Peripheral Lung Lesions. Results of the AQuIRE Registry. Am J Respir Crit Care Med. 2016 Jan 1;193(1):68-77. doi: 10.1164/rccm.201507-1332OC.
Results Reference
background
PubMed Identifier
33369988
Citation
Gildea TR, Folch EE, Khandhar SJ, Pritchett MA, LeMense GP, Linden PA, Arenberg DA, Rickman OB, Mahajan AK, Singh J, Cicenia J, Mehta AC, Lin H, Mattingley JS; NAVIGATE Study Investigators. The Impact of Biopsy Tool Choice and Rapid On-Site Evaluation on Diagnostic Accuracy for Malignant Lesions in the Prospective: Multicenter NAVIGATE Study. J Bronchology Interv Pulmonol. 2021 Jul 1;28(3):174-183. doi: 10.1097/LBR.0000000000000740.
Results Reference
background
PubMed Identifier
32450240
Citation
Folch EE, Labarca G, Ospina-Delgado D, Kheir F, Majid A, Khandhar SJ, Mehta HJ, Jantz MA, Fernandez-Bussy S. Sensitivity and Safety of Electromagnetic Navigation Bronchoscopy for Lung Cancer Diagnosis: Systematic Review and Meta-analysis. Chest. 2020 Oct;158(4):1753-1769. doi: 10.1016/j.chest.2020.05.534. Epub 2020 May 23.
Results Reference
background
PubMed Identifier
27174878
Citation
Mondoni M, Sotgiu G, Bonifazi M, Dore S, Parazzini EM, Carlucci P, Gasparini S, Centanni S. Transbronchial needle aspiration in peripheral pulmonary lesions: a systematic review and meta-analysis. Eur Respir J. 2016 Jul;48(1):196-204. doi: 10.1183/13993003.00051-2016. Epub 2016 May 12.
Results Reference
background
PubMed Identifier
35986257
Citation
Kim YW, Kim HJ, Yoon SH, Lee KH, Park YM, Ahn SY, Song MJ, Kwon BS, Lim SY, Lee YJ, Park JS, Cho YJ, Yoon HI, Lee JH, Lee CT. Evaluation of the synergistic impact of needle and forceps biopsy with electromagnetic navigation bronchoscopy: the CONFIDENT-ENB trial design. BMC Pulm Med. 2022 Aug 19;22(1):319. doi: 10.1186/s12890-022-02104-w.
Results Reference
derived

Learn more about this trial

Evaluation of the Synergistic Impact of Needle and Forceps Biopsy With Electromagnetic Navigation Bronchoscopy

We'll reach out to this number within 24 hrs